Spotlight

May is ALS Awareness Month

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Motor neurons reach from the brain to the spinal cord and from the spinal cord to the muscles throughout the body. The progressive degeneration of the motor neurons in people with ALS eventually leads to their death.

Asuragen is committed to advancing the understanding of ALS by providing clinical researchers with the tools necessary to investigate challenging gene targets like C9orf72 associated with ALS and frontotemporal dementia. Our AmplideX PCR/CE C9orf72 Kit* overcomes the challenges of analyzing the C9orf72 gene so clinical and pharmaceutical researchers can focus on what matters most – scientific breakthroughs that drive better outcomes for patients.

ALS VideoMany people have heard of ALS, but very few know what the disease is or what it’s like for those living with it. The ALS Association created a video to help shed light on the signs and symptoms of ALS.
Watch it here »

Raising awareness is critical to increasing support for patients, advocacy groups and the research programs that fuel global collaboration to drive the discovery of treatments and a cure for ALS. This May, there are many things you can do to help make a difference:

  • Educate others – spread the word, raise awareness and share the video
  • Increase visibility of ALS Awareness Month – use the hashtag #ALSaware
  • Follow us on Twitter & Facebook and share our posts with your networks

For more information on ALS, or to see how you can get involved, visit www.alsa.org.
Click here to learn more about Asuragen Genetics.

*For Research Use Only. Not for use in diagnostic procedures.

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close